中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
31期
22-23
,共2页
秦立%石海莉%黄捷%宋昆鹏%李艳%白起君
秦立%石海莉%黃捷%宋昆鵬%李豔%白起君
진립%석해리%황첩%송곤붕%리염%백기군
中药复方%冠心病%治疗性血管新生
中藥複方%冠心病%治療性血管新生
중약복방%관심병%치료성혈관신생
TCM combined medicine%Coronary heart disease%Therapeutic angiogenesis
目的:观察并探讨中药复方对冠心病治疗性血管新生的作用。方法:选择实验用大鼠30只作为本次实验对象,将大鼠随机分为观察1组、观察2组与对照组3组,每组10只。观察1组作为中药组,观察2组为贝复济组,对照组为空白组。作大鼠心肌缺血实验模型,术后分别给药,观察3组大鼠EC、CD、VEGF及bFGF表达。结果:观察1组、观察2组大鼠CD与EC分布且与对照组比较,具有显著性差异(P<0.05);观察1组与观察2组VEGF及bFGF反应与对照组比较,结果具有显著性差异(P<0.05)。结论:中药复方可促进冠心病治疗性血管新生作用,其在临床上的应用还有待于进一步临床验证。
目的:觀察併探討中藥複方對冠心病治療性血管新生的作用。方法:選擇實驗用大鼠30隻作為本次實驗對象,將大鼠隨機分為觀察1組、觀察2組與對照組3組,每組10隻。觀察1組作為中藥組,觀察2組為貝複濟組,對照組為空白組。作大鼠心肌缺血實驗模型,術後分彆給藥,觀察3組大鼠EC、CD、VEGF及bFGF錶達。結果:觀察1組、觀察2組大鼠CD與EC分佈且與對照組比較,具有顯著性差異(P<0.05);觀察1組與觀察2組VEGF及bFGF反應與對照組比較,結果具有顯著性差異(P<0.05)。結論:中藥複方可促進冠心病治療性血管新生作用,其在臨床上的應用還有待于進一步臨床驗證。
목적:관찰병탐토중약복방대관심병치료성혈관신생적작용。방법:선택실험용대서30지작위본차실험대상,장대서수궤분위관찰1조、관찰2조여대조조3조,매조10지。관찰1조작위중약조,관찰2조위패복제조,대조조위공백조。작대서심기결혈실험모형,술후분별급약,관찰3조대서EC、CD、VEGF급bFGF표체。결과:관찰1조、관찰2조대서CD여EC분포차여대조조비교,구유현저성차이(P<0.05);관찰1조여관찰2조VEGF급bFGF반응여대조조비교,결과구유현저성차이(P<0.05)。결론:중약복방가촉진관심병치료성혈관신생작용,기재림상상적응용환유대우진일보림상험증。
Objective:To observe and analyze clinical effects of TCM medicine on coronary heart disease therapeutic angiogenesis. Methods:30 rats were randomly divided into the observation group 1 (TCM medicine group), the observation group 2 (bFGF group) and the control group (blank group). Myocardial ischemia modes were made, EC,CD, VEGF and bFGF expression of rats in three groups were observed. Results: CD, EC distribution in the observation 1 and the observation 2 has statistically significant compared with the control group (P<0.05);the same as VEGF and bFGF reactions (P<0.05). Conclusion:TCM medicine can improve the function of coronary heart disease therapeutic angiogenesis, its application needs more examination.